MYO (Myomo, Inc) EV/EBITDA Multiple

Corporate emblem and logo of Myomo (MYO)

Myomo, Inc. (MYO) is developing partnerships with hospitals and rehabilitation centers to implement MyoPro robotic systems. This EV/EBITDA price action chart reflects a current metric of 0.00. The company leads the production of myoelectric exoskeletons that utilize nerve impulses to restore arm mobility. Demand for these devices is increasing due to expanded insurance coverage and an influx of new customers in the US.

Myomo Inc - MYO Enterprise Value to Operating Income Before Depreciation (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for myomo.com (MYO)

- stock price and consensus target price:
Stock Quotes Myomo, Inc|MYO - Forecast Levels Chart
- business market valuation indicators:
Market Capitalization Myomo Inc|MYO - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Myomo|MYO - Accounting Capitalization|Market Cap to Net Assets Ratio myomo.com|MYO - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Myomo, Inc.|MYO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Myomo|MYO - Company Cumulative Debt|Debts to Book Capitalization Myomo Inc|MYO - Company Long-Term Indebtedness|Company Short-Term Debts Myomo|Quick Ratio myomo.com
- financial results and valuation multiples details:
MYO - Net Income|Projected Future Earnings Myomo, Inc.|MYO - P/E Multiple|Future Price to Earnings Myomo, Inc.|MYO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Myomo Inc|MYO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Myomo|MYO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months myomo.com|MYO - Net earnings per share change in current year|Expected earnings per share growth for next year Myomo, Inc.
Initial company analysis:Myomo, Inc MYO
Original product of myomo.com

Professional issuer selection is based on an analysis of business value relative to its operating profit before depreciation and interest. This ratio measures the credit resilience of Myomo, Inc., reflecting the impact of robotization costs for MyoPro exoskeleton calibration on total capitalization, which allows the EV/EBITDA multiple trend to determine the company's real market value between quarterly reports.

Competitor analysis for Myomo, Inc.

Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|ResMed Inc. - EV/EBITDA Multiple|Company Value to EBITDA insulet.com|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation COO|Enterprise Value to EBITDA Ratio ALGN|GMED: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics (TMDX)|Enterprise Value to EBITDA Ratio atecspine.com ATEC|EV/EBITDA Multiple AORT (Artivion)|Enovis Corp (ENOV) - Company Value to EBITDA|Integra - EV/EBITDA Multiple|ESTA (Establishment Labs Inc) - Enterprise Value to Operating Income Before Depreciation|BBNX: EV/EBITDA Multiple|IRMD - Total Company Value to Operating Income Before Depreciation Ratio|EMBC (Embecta) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tandem Diabetes Care Inc (TNDM)|EV/EBITDA Multiple AXGN|EV/EBITDA Multiple SI-BONE Medical (SIBN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orthofix Medical Inc. OFIX|bioventus.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KIDS: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TMCI (Treace Medical Concepts Inc)|SRTA: EV/EBITDA Multiple|Company Value to EBITDA Carlsmed Medical (CARL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RxSight, Inc.|CLPT - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STXS (Stereotaxis)|EV/EBITDA Multiple Neuronetics Inc. (STIM)|EV/EBITDA Multiple SGHT (Sight Sciences, Inc)|Total Company Value to Operating Income Before Depreciation Ratio orchestrabiomed.com (OBIO)|ANIK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Vivani Medical|XTNT (Xtant Medical Holdings, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA NeuroOne Medical Technologies Corp. NMTC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Modular Medical (MODD)|envoymedical.com - Enterprise Value to Operating Income Before Depreciation|Vivos Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NVNO (enVVeno Medical Corporation)|SINT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Tenon Medical Inc (TNON) - Enterprise Value to EBITDA Ratio|LFWD (ReWalk Robotics Ltd.) - Enterprise Value to EBITDA Ratio|Company Value to EBITDA Autonomix Medical (AMIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|Enterprise Value to EBITDA Ratio Biolase Inc. BIOL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO: Enterprise Value to EBITDA Ratio